Loading clinical trials...
Loading clinical trials...
In this study, memantine will be tested in a new indication: in the treatment of subjective memory, concentration, or attention problems (subjective cognitive impairment) in the absence of dementia.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Merz Pharmaceuticals GmbH
NCT07191197 · Amnesia, Memory Disorder
NCT04725409 · Psychiatric Disorder, Memory Disorders
NCT06584357 · Mild Cognitive Impairment, Alzheimer's Disease, and more
NCT05668598 · Memory Disorders, Neurocognitive Disorders
NCT06853405 · Cognitive Dysfunction, Cognition Disorder, and more
Universitätsklinikum der RWTH Aachen
Aachen
Praxis Dr. Heidenreich
Böblingen
Universitätsklinikum Carl Gustav Carus
Dresden
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions